The Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

AI is transforming healthcare in India’s smaller towns. From handheld diagnostic devices to cloud-powered imaging, even local clinics can now offer expert-level care. Faster, affordable, and ...

On Saturday, Sept. 16, 2023, Sam Terblanche, a junior at Columbia University, went to a soccer match at Yankee Stadium. On ...

Background Stillbirth rates remain unacceptably high in low- and middle-income countries (LMICs). Understanding the causes of ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Levofloxacin-induced myopathy is a relatively under-recognized adverse effect. Here, we present a case of myopathy affecting ...